42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico,...

7
42

Transcript of 42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico,...

Page 1: 42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico, August 14 -18 , 2011 Evaluation of the protection against a very virulent (vv) Infectious

42 43

Page 2: 42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico, August 14 -18 , 2011 Evaluation of the protection against a very virulent (vv) Infectious

42 43

Page 3: 42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico, August 14 -18 , 2011 Evaluation of the protection against a very virulent (vv) Infectious

44 45

Page 4: 42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico, August 14 -18 , 2011 Evaluation of the protection against a very virulent (vv) Infectious

44 45

Page 5: 42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico, August 14 -18 , 2011 Evaluation of the protection against a very virulent (vv) Infectious

46 47

Page 6: 42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico, August 14 -18 , 2011 Evaluation of the protection against a very virulent (vv) Infectious

46 47

Page 7: 42 43vaxxitek.com/sites/vaxxitek.com/files/vaxxitek...th th XVII WVPA Congress Cancun, Mexico, August 14 -18 , 2011 Evaluation of the protection against a very virulent (vv) Infectious

48 49